The challenges of using blood-based miRNAs in the clinic
This preprint addresses the enormous challenges confronting researchers invested in serum miRNAs and their potential use as clinical biomarkers. We discuss some of the inherent technical obstacles and suggest several possible solutions. We hope to encourage all researchers to be united and collaborative in the pursuit of delivering clinically relevant biomarkers in the near future.
Please use this identifier to cite or link to this item: